The historical rank and industry rank for Ocera Therapeutics's Net Margin % or its related term are showing as below:
OCRX's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -162.58 * Ranked among companies with meaningful Net Margin % only.
Ocera Therapeutics Net Margin % Historical Data
The historical data trend for Ocera Therapeutics's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ocera Therapeutics's Net Margin %
For the Biotechnology subindustry, Ocera Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocera Therapeutics's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ocera Therapeutics's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ocera Therapeutics's Net Margin % falls into.
Ocera Therapeutics Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Ocera Therapeutics's Net Margin for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocera Therapeutics (NAS:OCRX) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ocera Therapeutics Net Margin % Related Terms
Thank you for viewing the detailed overview of Ocera Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Ocera Therapeutics (Ocera Therapeutics) Business Description
Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company, which primarily targets acute and chronic orphan liver diseases. The company is focused on the development and commercialization of a clinical product candidate, OCR-002 for the treatment of acute and chronic hepatic encephalopathy for patients with a serious complication of liver cirrhosis, or liver failure, marked by mental changes including confusion, impaired motor skills, disorientation in time and space, and, in its more severe form, stupor, coma and even death. All the business activity of the firm is functioned through the region of US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OCRX has been successfully added to your 